Aerosolized Sargramostim Added to Immunotherapy for the Treatment of Patients With Metastatic Melanoma to the Lung

Clinical trial NCT05717140 · WITHDRAWN

Trial details

NCT number: NCT05717140
Sponsor: Mayo Clinic
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Clinical Stage IV Cutaneous Melanoma AJCC v8 Metastatic Malignant Neoplasm in the Lung Metastatic Melanoma Recurrent Melanoma Unresectable Melanoma

Start date: 2025-10-28
Primary completion: 2026-01-28
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.